IZZI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 11.192
AS - Asia 1.992
EU - Europa 1.688
Continente sconosciuto - Info sul continente non disponibili 341
SA - Sud America 313
AF - Africa 57
OC - Oceania 8
Totale 15.591
Nazione #
US - Stati Uniti d'America 11.086
SG - Singapore 798
IT - Italia 489
CN - Cina 360
BR - Brasile 259
RU - Federazione Russa 248
IE - Irlanda 192
VN - Vietnam 177
BD - Bangladesh 172
DE - Germania 171
HK - Hong Kong 164
GB - Regno Unito 128
KR - Corea 109
FR - Francia 84
UA - Ucraina 84
FI - Finlandia 81
JP - Giappone 73
CA - Canada 71
NL - Olanda 52
SE - Svezia 33
IN - India 32
AR - Argentina 23
AT - Austria 23
ID - Indonesia 21
PL - Polonia 19
EG - Egitto 18
MX - Messico 18
CZ - Repubblica Ceca 17
TR - Turchia 17
ZA - Sudafrica 16
ES - Italia 15
BE - Belgio 10
IQ - Iraq 9
PH - Filippine 9
CL - Cile 8
CH - Svizzera 7
GR - Grecia 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
EC - Ecuador 5
KE - Kenya 5
PE - Perù 5
RO - Romania 5
BA - Bosnia-Erzegovina 4
CO - Colombia 4
DK - Danimarca 4
DZ - Algeria 4
ET - Etiopia 4
HN - Honduras 4
JM - Giamaica 4
MY - Malesia 4
NP - Nepal 4
QA - Qatar 4
SA - Arabia Saudita 4
TW - Taiwan 4
EU - Europa 3
HU - Ungheria 3
KZ - Kazakistan 3
LT - Lituania 3
PK - Pakistan 3
PY - Paraguay 3
TH - Thailandia 3
AZ - Azerbaigian 2
BB - Barbados 2
CR - Costa Rica 2
HR - Croazia 2
IL - Israele 2
IR - Iran 2
JO - Giordania 2
LB - Libano 2
LK - Sri Lanka 2
MA - Marocco 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
BW - Botswana 1
GE - Georgia 1
GP - Guadalupe 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NR - Nauru 1
RS - Serbia 1
SC - Seychelles 1
SV - El Salvador 1
TD - Ciad 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.254
Città #
Wilmington 2.560
Houston 2.465
Woodbridge 1.581
Ashburn 519
Singapore 480
Fairfield 407
Chandler 325
San Jose 284
Seattle 202
Council Bluffs 195
Beijing 174
Dublin 165
Cambridge 160
Hong Kong 157
New York 155
Ann Arbor 150
Rome 120
Medford 115
Santa Clara 109
Los Angeles 105
The Dalles 78
Dearborn 72
Helsinki 56
Ho Chi Minh City 55
Lawrence 54
Buffalo 51
Milan 51
Tokyo 51
Lauterbourg 47
Dallas 45
Hanoi 44
Menlo Park 40
Monte Vista 40
Munich 40
Moscow 39
San Diego 35
Boardman 34
Jacksonville 34
São Paulo 33
Orem 27
Toronto 25
Chicago 23
London 23
North Bergen 22
Denver 19
Montreal 18
Amsterdam 17
Brooklyn 17
Columbus 17
Atlanta 16
Brno 16
Seoul 16
Stockholm 15
Miano 14
Phoenix 14
San Francisco 14
Warsaw 14
Norwalk 13
Redwood City 13
Cairo 12
Istanbul 12
Jakarta 12
Manchester 12
Boston 11
Frankfurt am Main 11
Johannesburg 11
Vienna 11
Belo Horizonte 10
Brussels 10
Da Nang 10
Naples 10
Salt Lake City 10
Bologna 9
Chennai 9
Kilburn 9
Nuremberg 9
Zhengzhou 9
Haiphong 8
Lappeenranta 8
Mexico City 8
Santiago 8
Tōyō 8
Guangzhou 7
Mumbai 7
Nanjing 7
Palo Alto 7
Philadelphia 7
Tsu 7
Washington 7
Athens 6
Bari 6
City of London 6
Las Vegas 6
Memphis 6
New Orleans 6
Poplar 6
Porto Alegre 6
Redondo Beach 6
Florence 5
Kunming 5
Totale 12.020
Nome #
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 510
Predicting seizures in untreated temporal lobe epilepsy using point-process nonlinear models of heartbeat dynamics 489
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 481
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 468
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 452
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 431
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 431
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 428
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 428
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 392
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 387
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 375
Folic acid supplements during pregnancy in specific clinical settings: What dowe know about epilepsy? 374
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 372
MicroRNA expression is dysregulated in narcolepsy: A new evidence? 368
Obstructive sleep apnoea and bone health 359
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 327
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 326
Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy? 306
Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study 298
Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study 296
Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? 287
Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms 271
Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording 270
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation 264
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 264
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 259
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine 256
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 250
Lower instantaneous entropy of heartbeat dynamics during seizures in untreated temporal lobe epilepsy 245
Seasonality of restless legs syndrome: symptom variability in winter and summer times 228
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid 206
Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies 205
Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis 192
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 191
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation 191
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 181
Pitolisant for treating narcolepsy comorbid with Parkinson's disease 179
Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer's disease biomarkers changes 178
Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1 166
The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1 159
Heart rate variability parameters during psychogenic non-epileptic seizures: comparison between patients with pure PNES and comorbid epilepsy 148
New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay! 141
Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder 136
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy 136
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy 127
A preliminary study investigating the clinical potential of measuring cerebrospinal-fluid lactate levels in patients with narcolepsy type 1 and 2 124
Obstructive sleep apnea syndrome and Alzheimer's disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration? 116
Sleep-wake cycle dysregulation in idiopathic REM sleep behaviour disorder 110
Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease. 102
Nocturnal hypoxia and sleep fragmentation may drive neurodegenerative processes: the compared effects of obstructive sleep apnea syndrome and periodic limb movement disorder on Alzheimer's disease biomarkers 102
Neuroimaging findings in leukoencephalopathy with calcifications and cysts: case report and review of the literature 99
Periodic sharp wave complexes identify a distinctive phenotype in Creutzfeldt-Jacob disease. 98
Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 95
Brivaracetam as early add-on treatment in patients with focal seizures: a retrospective, multicenter, real-world study 90
Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder 89
Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort 88
Effectiveness of Highly Purified Cannabidiol in Refractory and Super-Refractory Status Epilepticus: A Case Series 87
Perampanel may represent an effective treatment for the prevention of migraine comorbid with epilepsy 84
Insular monoaminergic deficits in prodromal α-synucleinopathies 81
Brainstem impairment in obstructive sleep apnoea and the effect of CPAP treatment: an electrophysiological blink reflex study 78
Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center 67
More than sleep and wake disturbances: An actigraphic study showing the sleep-wake pattern dysregulation in epilepsy 65
Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI 63
Continuous positive airway pressure treatment improves bone mineral density in men affected by severe obstructive sleep apnea syndrome 60
Sleep Dysregulation Is Associated with 18F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease 56
Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance 52
OBSTRUCTIVE SLEEP APNEA AS A RISK FACTOR FOR OSTEOPENIA AND OSTEOPOROSIS IN THE MALE POPULATION 44
Gut microbiome composition changes in obstructive sleep apnoea syndrome also in relation to excessive daytime sleepiness 19
Blood-brain barrier impairment as an early marker of neurodegeneration in late-onset epilepsy of unknown origin 17
Cenobamate modulates EEG cortical activity and connectivity in individuals with drug-resistant epilepsy: a pharmaco-EEG study 17
Increased neutrophil-to-lymphocyte ratio as a possible marker to detect neuroinflammation in patients with narcolepsy type 1 16
Sleep architecture in drug-naïve adult patients with epilepsy: Comparison between focal and generalized epilepsy 15
The potential role of interleukin-6 in the association between inflammation and cognitive performance in obstructive sleep apnea 15
Sex effect on time to diagnosis and clinical features of narcolepsy type 1 and 2 15
Perampanel effects on cognition and quantitative EEG in patients with epilepsy 14
Alexithymia, impulsiveness, emotion, and eating dyscontrol: similarities and differences between narcolepsy type 1 and type 2 14
The effect of lacosamide monotherapy on sleep architecture in patients with epilepsy: a preliminary evidence 14
Perampanel Increases Cortical EEG Fast Activity in Child and Adult Patients Affected by Epilepsy: A Quantitative EEG Study 13
Cognitive functioning, cerebrospinal fluid Alzheimer's disease biomarkers and cerebral glucose metabolism in late‐onset epilepsy of unknown aetiology: A prospective study 13
CSF dynamics of orexin and β-amyloid42 levels in narcolepsy and Alzheimer’s disease patients: a controlled study 13
Commentary: Sleep changes without medial temporal lobe or brain cortical changes in community-dwelling individuals with subjective cognitive decline 13
Integrating postural and vestibular dimensions to depict impairment in moderate-to-severe obstructive sleep apnea syndrome patients 12
The Sleepiness–Depression Link in Obstructive Sleep Apnea: Preliminary Results on the Mediation of Impulsivity 12
Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study 12
Variability of excessive daytime sleepiness and cataplexy according to seasonality: A study in central disorders of hypersomnolence 11
Vitamin D status of male OSAS patients improved after long-term CPAP treatment mainly in obese subjects 11
Refractory restless legs syndrome remitting after dual kidney transplantation 11
Persistent blood-brain barrier dysregulation in patients with obstructive sleep apnea following long-term continuous positive airway pressure treatment 10
Oral l-carnitine as treatment for narcolepsy without cataplexy during pregnancy: A case report 10
Letter re: Prolonged sleep duration as a marker of early neurodegeneration predicting incident dementia 9
null 7
Totale 15.591
Categoria #
all - tutte 51.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.649


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022634 0 46 26 11 16 18 65 15 33 53 40 311
2022/2023846 103 77 39 104 69 174 65 53 84 16 37 25
2023/2024443 43 10 24 23 36 146 21 37 8 27 6 62
2024/20251.391 62 286 148 97 36 121 67 67 142 122 140 103
2025/20263.360 251 80 332 301 243 124 398 323 328 291 471 218
2026/2027634 443 191 0 0 0 0 0 0 0 0 0 0
Totale 15.591